N(4)-Hydroxycytidine CAS 3258-02-4 EIDD-1931 NHC High Quality

Kufotokozera Kwachidule:

Dzina la Mankhwala: N(4)-Hydroxycytidine

Mawu ofanana: EIDD-1931 (NHC);β-D-N4-Hydroxycytidine

CAS: 3258-02-4

Maonekedwe: Ufa Woyera mpaka WoyeraChiyero: ≥98.0%

Metabolite yogwira ya Molnupiravir (EIDD-2801), yodalirika ya COVID-19 inhibitor

Ubwino Wapamwamba, Kupanga Zamalonda

Inquiry: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Perekani ndi Kuyera Kwambiri ndi Ubwino Wokhazikika
Dzina la Mankhwala: N (4) -Hydroxycytidine;EIDD-1931 (NHC)
CAS: 3258-02-4
Metabolite yogwira ya Molnupiravir, yolonjeza ya COVID-19 inhibitor

Chemical Properties:

Dzina la Chemical N(4)-Hydroxycytidine
Mawu ofanana ndi mawu EIDD-1931 (NHC);β-D-N4-Hydroxycytidine
Nambala ya CAS 3258-02-4
Nambala ya CAT RF-PI309
Stock Status Mu Stock, Production Scale Up to Kilograms
Molecular Formula Chithunzi cha C9H13N3O6
Kulemera kwa Maselo 259.22
Melting Point 169.0 ~ 172.0 ℃
Kusungunuka Kusungunuka mpaka 100 mM mu DMSO ndi 50 mM mu Madzi
Kuchulukana 1.93±0.1 g/cm3
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera mpaka Woyera
NMR Zogwirizana ndi Kapangidwe
Kuyera / Kusanthula Njira >98% (HPLC)
Kutaya pa Kuyanika ≤1.0%
Chidetso Chimodzi ≤0.50%
Zitsulo Zolemera ≤20ppm
Test Standard Enterprise Standard
Kugwiritsa ntchito Metabolite yogwira ya Molnupiravir (EIDD-2801), inhibitor ya COVID-19

Phukusi & Kusungira:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, makatoni ng'oma, 25kg / Drum, kapena malinga ndi zofuna za kasitomala.

Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala, chinyezi ndi tizilombo towononga.

Ubwino:

1

FAQ:

Ntchito:

N(4)-Hydroxycytidine (EIDD-1931, β-d-N4-hydroxycytidine, NHC, CAS 3258-02-4) ndi metabolite yogwira ya EIDD-2801, yolonjeza COVID-19 inhibitor.EIDD-1931 (NHC) ili ndi zochita zambiri zolimbana ndi ma virus angapo, kuphatikiza SARS-CoV-2, MERS-CoV, SARS-CoV, ndi gulu lofananira la zoonotic 2b kapena 2c Bat-CoVs okhala ndi pafupifupi IC50 ya 0.15 μM, komanso kuchuluka kwa potency motsutsana ndi coronavirus yolimbana ndi kusintha kwa nucleoside analog inhibitor remdesivir.Mu mbewa zomwe zili ndi SARS-CoV kapena MERS-CoV, onse prophylactic ndi achire kasamalidwe ka Molnupiravir (EIDD-2801), pakamwa bioavailable NHC-prodrug (β-D-N4-hydroxycytidine-5'-isopropyl ester), bwino pulmonary ntchito , ndi kuchepetsa chiwerengero cha ma virus komanso kuchepa thupi.Kuchepetsa zokolola za MERS-CoV mu vitro ndi mu vivo zimalumikizidwa ndi kuchuluka kwa kusintha kwakusintha kwa ma virus koma osati ma cell a RNA, kuthandizira njira yakupha mutagenesis mu CoV.Mphamvu ya NHC/EIDD-2801 yolimbana ndi ma coronavirus angapo komanso kupezeka kwapakamwa kumawonetsa momwe angagwiritsire ntchito ngati antivayirasi yolimbana ndi SARS-CoV-2 ndi ma coronavirus ena amtsogolo a zoonotic.

Lembani uthenga wanu apa ndikutumiza kwa ife